Do CSF levels of t-Tau, p-Tau and β1-42 amyloid correlate with dopaminergic system impairment in patients with a clinical diagnosis of Parkinson disease? A 123I-FP-CIT study in the early stages of the disease
Crossref DOI link: https://doi.org/10.1007/s00259-014-2841-4
Published Online: 2014-07-10
Published Print: 2014-11
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Chiaravalloti, Agostino
Stefani, Alessandro
Fiorentini, Alessandro
Lacanfora, Annamaria
Stanzione, Paolo
Schillaci, Orazio
Text and Data Mining valid from 2014-07-10